Casciano Anthony 4
4 · AMAG PHARMACEUTICALS, INC. · Filed Mar 12, 2020
Insider Transaction Report
Form 4
Casciano Anthony
Chief Commercial Officer
Transactions
- Award
Common Stock
2020-03-10+25,000→ 78,209 total - Award
Stock Option (Right to Buy)
2020-03-10+40,000→ 40,000 totalExercise: $7.27Exp: 2030-03-10→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan") that will vest in three equal annual installments with the first installment vesting on March 10, 2021.
- [F3]Not applicable.
- [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.